Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q3

2796.TEDINET S100T8YK
Period2023-06-01 → 2024-02-29
Filed2024-04-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥40.7bn2023-06-01 → 2024-02-29Cons.Net sales
Revenue¥52.0bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥38.7bn2022-06-01 → 2023-02-28Cons.Net sales
Operating income¥863m2023-06-01 → 2024-02-29Cons.Operating income
Operating income¥896m2022-06-01 → 2023-02-28Cons.Operating income
Ordinary income¥799m2023-06-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.4bn2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥890m2022-06-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥761m2023-06-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥722m2022-06-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥177m2023-06-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥333m2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥208m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥187m2023-06-01 → 2024-02-29Cons.Profit loss
Net income¥218m2022-06-01 → 2023-02-28Cons.Profit loss
Total assets¥26.4bnat 2024-02-29Cons.Assets
Total assets¥23.4bnat 2023-05-31Cons.Assets
Total assets¥22.9bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥18.5bnat 2024-02-29Cons.Liabilities
Total liabilities¥16.4bnat 2023-05-31Cons.Liabilities
Net assets / equity¥8.0bnat 2024-02-29Cons.Net assets
Net assets / equity¥7.0bnat 2023-05-31Cons.Net assets
Net assets / equity¥6.8bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥5.2bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥4.7bnat 2023-05-31Cons.Cash and deposits
EPS (basic)¥17.222023-06-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.422023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.452022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.242022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.452022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥16.482023-06-01 → 2024-02-29Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.892022-06-01 → 2023-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥16.892022-06-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio29.0%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio28.5%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.4%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-06-01 → 2024-02-29¥593m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-06-01 → 2024-02-29¥593m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-06-01 → 2024-02-29¥5m
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2024-02-29−¥250m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2023-06-01 → 2024-02-29¥6.2bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2023-06-01 → 2024-02-29¥6.2bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2023-06-01 → 2024-02-29−¥45m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2023-06-01 → 2024-02-29¥456m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2023-06-01 → 2024-02-29¥456m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2023-06-01 → 2024-02-29¥33m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2023-06-01 → 2024-02-29¥33.1bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2023-06-01 → 2024-02-29¥33.1bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2023-06-01 → 2024-02-29¥1.0bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2023-06-01 → 2024-02-29¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2023-06-01 → 2024-02-29¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2023-06-01 → 2024-02-29¥83m
—segment totalrevenue2023-06-01 → 2024-02-29¥40.1bn
—segment totalrevenue external2023-06-01 → 2024-02-29¥40.1bn
—segment totalsegment profit2023-06-01 → 2024-02-29¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-02-29¥40.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-02-29¥40.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-02-29¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2023-02-28¥37m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥226m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2023-02-28−¥170m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2023-02-28¥56m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2023-02-28¥1.1bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2023-02-28¥70m
—segment totalrevenue2022-06-01 → 2023-02-28¥38.2bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥38.2bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 396
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member321100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.026
Number of shares held in own name treasury shares etcCurrentQuarterInstant321100
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant321100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.026
Number of male directors and other officersFilingDateInstant10
Number of female directors and other officersFilingDateInstant3
Ratio of female directors and other officersFilingDateInstant0.231
Cash and depositsPrior1YearInstant4742000000JPY
Cash and depositsCurrentQuarterInstant5164000000JPY
Accounts receivable tradePrior1YearInstant611000000JPY
Accounts receivable tradeCurrentQuarterInstant642000000JPY
Merchandise and finished goodsPrior1YearInstant2225000000JPY
Merchandise and finished goodsCurrentQuarterInstant3256000000JPY
Raw materials and suppliesPrior1YearInstant65000000JPY
Raw materials and suppliesCurrentQuarterInstant73000000JPY
Accounts receivable otherPrior1YearInstant3412000000JPY
Accounts receivable otherCurrentQuarterInstant2268000000JPY
Other caPrior1YearInstant320000000JPY
Other caCurrentQuarterInstant361000000JPY
Allowance for doubtful accounts caPrior1YearInstant-6000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-6000000JPY
Current assetsPrior1YearInstant11372000000JPY
Current assetsCurrentQuarterInstant11761000000JPY
Buildings and structures netPrior1YearInstant2902000000JPY
Buildings and structures netCurrentQuarterInstant2963000000JPY
LandPrior1YearInstant2587000000JPY
LandCurrentQuarterInstant2609000000JPY
Other net ppePrior1YearInstant519000000JPY
Other net ppeCurrentQuarterInstant504000000JPY
Property plant and equipmentPrior1YearInstant6010000000JPY
Property plant and equipmentCurrentQuarterInstant6077000000JPY
GoodwillPrior1YearInstant2748000000JPY
GoodwillCurrentQuarterInstant2509000000JPY
Other iaPrior1YearInstant502000000JPY
Other iaCurrentQuarterInstant538000000JPY
Intangible assetsPrior1YearInstant3250000000JPY
Intangible assetsCurrentQuarterInstant3047000000JPY
Investment securitiesPrior1YearInstant82000000JPY
Investment securitiesCurrentQuarterInstant2781000000JPY
Other ioaPrior1YearInstant2858000000JPY
Other ioaCurrentQuarterInstant2949000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-152000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-192000000JPY
Investments and other assetsPrior1YearInstant2787000000JPY
Investments and other assetsCurrentQuarterInstant5538000000JPY
Noncurrent assetsPrior1YearInstant12048000000JPY
Noncurrent assetsCurrentQuarterInstant14663000000JPY
Deferred assetsPrior1YearInstant0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-05-31pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass